Pain Threshold Changes in Rats Following Central Injection of Beta-Endorphin, Met-Enkephalin, Vasopressin or Oxytocin Antisera

References

• Belluzzi J. D., Grant N., Garsky V., Sarantakis D., Wise C. D., Stein L. Analgesia induced in vivo by central administration of enkephalin in rat. Nature 1976; 260: 625–626
   PubMed Web of Science ®Google Scholar
• Berkowitz B. A., Sherman S. Characterization of vasopressin analgesia. Journal of Pharmacology and Experimental Therapeutics 1982; 220: 329–334
   PubMed Web of Science ®Google Scholar
• Berntson G. G., Berson B. S. Antinociceptive effects of intraventricular or systemic administration of vasopressin in the rat. Life Sciences 1980; 26: 455–459
   PubMed Web of Science ®Google Scholar
• Bloom F. E., Segal D., Ling N., Guillemin R. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science 1976; 194: 630–632
   PubMed Web of Science ®Google Scholar
• Bodnar R. J., Kelly D. D., Brutus M., Glusman M. Stress-induced analgesia: neural and hormonal determinants. Neuroscience and Biobehavioral Reviews 1980; 4: 87–100
   PubMed Web of Science ®Google Scholar
• Bodnar R. J., Wallace M. M., Nilaver G., Zimmerman E. A. The effects of centrally administered antisera to neurotensin and related peptides upon nociception and related behaviors. Annals of the New York Academy of Sciences 1982; 400: 244–258
   Google Scholar
• Bodnar R. J., Zimmerman E. A., Nilaver G., Mansour A., Thomas L., Kelly D. D., Glusman M. Dissociation of cold-water swim analgesia and morphine analgesia in Brattleboro rats with diabetes insipidus. Life Sciences 1980; 26: 1581–1590
   PubMed Web of Science ®Google Scholar
• Clineschmidt B., McGuffin J. Neurotensin adminstered intracisternally inhibits responsiveness of mice to noxious stimuli. European Journal of Pharmacology 1977; 46: 395–396
   Google Scholar
• Coderre T. J., Rollman G. B. Naloxone hyperalgesia and stress-induced analgesia in rats. Life Sciences 1983; 32: 2139–2146
   Google Scholar
• D'Amour F. E., Smith D. L. A method for determining loss of pain sensation. Journal of Pharmacology and Experimental Therapeutics 1941; 72: 74–79
   Google Scholar
• Evans W. O. A new technique for the investigation of some analgesic drugs on a reflexive behavior in the rat. Psychopharmacology 1961; 2: 318–825
   Google Scholar
• Frederickson R. C. A., Burgis V., Harrell C. E., Edwards J. D. Dual actions of substance P on nociception: possible role of endogeneous opioids. Science 1978; 199: 1359–1362
   PubMed Web of Science ®Google Scholar
• Graf L., Szekely J. I., Ronai A. Z., Dunai-Kovacs Z., Bajusz S. Comparative study on analgesic effect of Met-enkephalin and related lipotropin fragments. Nature 1976; 263: 240–241
   PubMed Web of Science ®Google Scholar
• Jacquet Y., Marks N. The C-fragment of betalipotropin: an endogenous neuroleptic or anti-psychotogen. Science 1976; 194: 632–635
   PubMed Web of Science ®Google Scholar
• Kelly D. D. Psychophysics of the tail-flick test: differential drug effects upon long and short latencies Society for Neuroscience Abstracts 1983; 9: 1061
   Google Scholar
• Kirchgessner A. L., Bodnar R. J., Pasternak G. W. Naloxazone and pain-inhibitory systems: evidence for a collateral inhibition model. Pharmacology, Biochemistry and Behavior 1982; 17: 1175–1179
   PubMed Web of Science ®Google Scholar
• Kordower J. H., Sikorszky V., Bodnar R. J. Central antinociceptive effects of lysine vasopressin and an analogue. Peptides 1982; 3: 613–617
   PubMed Web of Science ®Google Scholar
• Kordower J. H., Bodnar R. J. Vasopressin analgesia: specificity of action and non-opioid effects. Peptides 1984; 5, in press
   Google Scholar
• Kruse H., Van Wimersma Greidanus T. J. B., De Wied D. Barrel rotation induced by vasopressin and related peptides in rats. Pharmacology, Biochemistry and Behavior 1978; 7: 311–313
   Google Scholar
• Levine J. D., Murphy D. D., Seidenwurm D., Cortez A., Fields H. L. A study of the quantal (all or none) change in reflex latency produced by opiate analgesics. Brain Research 1980; 200: 129–141
   Google Scholar
• Malick J. B., Goldstein J. M. Analgesic activity of substance P following intracerebral administration in rats. Life Sciences 1978; 23: 835–844
   PubMed Web of Science ®Google Scholar
• Naranjo J. R., Sanchez-Franco F., DelRio J. Blockade by met-enkephalin antiserum of analgesia induced by substance P in mice. Neuropharmacology 1982; 21: 1295–1299
   Google Scholar
• Naranjo J. R., Sanchez-Franco F., Garzon J., DelRio J. Analgesic activity of substance P in rats: apparent mediation by met-enkephalin release. Life Sciences 1982; 30: 441–446
   PubMedGoogle Scholar
• Nemeroff C. B., Osbahr A. J., Manberg P. J., Ervin G. N., Prange A. J. Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin other endogenous peptides and morphine. Proceedings of the National Academy of Sciences 1979; 76: 5368–5371
   Google Scholar
• Odell W., Skowsky R., Abraham G., Hescox M., Fisher D., Grover P. K. Production of antisera for polypeptide and steriod radioimmunoassays. Biological Reproduction 1972; 6: 427–442
   Google Scholar
• Oehme P., Hilse H., Morgenstern E., Gores E. Substance P: does it produce analgesia or hyperalgesia?. Science 1980; 208: 305–307
   PubMed Web of Science ®Google Scholar
• Osbahr A. J., Nemeroff C. B., Luttinger D., Mason G. A., Prange A. J. Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone. Journal of Pharmacology and Experimental Therapeutics 1981; 217: 645–651
   Google Scholar
• Price D. D., Dubner R. Neurons that subserve the sensory-discriminative aspects of pain. Pain 1977; 3: 303–338
   Google Scholar
• Sawynok J., Pinsky C., LaBella F. S. On the specificity of naloxone as an opiate antagonist. Life Sciences 1979; 25: 1621–1632
   PubMed Web of Science ®Google Scholar
• Simone D. A., Bodnar R. J., Pasternak G. W. Naloxonazine: dose-dependent and test-dependent effects upon morphine analgesia. Society for Neuroscience Abstracts 1983; 9: 892
   Google Scholar
• Stewart J. M., Getto C. J., Neldner K., Basil-Reeve E., Krivoy W. A., Zimmerman E. Substance P and analgesia. Nature 1976; 262: 784–785
   Google Scholar
• Vaitukaitas J., Robbins J. B., Nieschlag E., Ross G. T. A method for producing specific antisera with small doses of immunogen. Journal of Clinical Endocrinology 1971; 33: 988–991
   Google Scholar
• Wallace M. M., Bodnar R. J., Badillo-Martinez D., Nilaver G., Zimmerman E. A. Role of neuropeptides in nociceptive processes. Society for Neuroscience Abstracts 1981; 7: 167
   Google Scholar
• Watkins L. R., Mayer D. J. The neural organization of endogenous opiate and non-opiate pain control systems. Science 1982; 216: 1185–1192
   PubMed Web of Science ®Google Scholar
• Watson S. J., Akil H., Richard C. W., Barchas J. D. Evidence for two separate opiate peptide neuronal systems. Nature 1978; 275: 226–228
   Google Scholar
• Xie G. X., Han J. S., Hollt V. Electroacupuncture analgesia blocked by microinjection of anti-beta-endorphin antiserum into periaqueductal gray of the rabbit. International Journal of Neuroscience 1983; 18: 287–292
   PubMed Web of Science ®Google Scholar
• Zimmerman E. A., Krupp L., Hoffman D. L., Matthew E., Nilaver G. Exploration of peptidergic pathways in brain by immunocytochernistry: a ten-year perspective. Peptides 1980; 1: 3–10, (Supplement)
   Web of Science ®Google Scholar